Sang, Christine N <br/><br/>
Phase IA Clinical Trial Evaluating the Tolerability, Pharmacokinetics, and Analgesic Efficacy of an Intrathecally Administered Neurotensin A Analogue in Central Neuropathic Pain Following Spinal Cord Injury.  [electronic resource] 

 -  Clinical pharmacology in drug development  Jul 2016 
 - 250-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>2160-7648 
<br/><br/><label>Standard No.: </label>10.1002/cpdd.253  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analgesics--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Glycoproteins--administration & dosage<br/>Humans<br/>Injections, Spinal<br/>Maximum Tolerated Dose<br/>Models, Biological<br/>Neuralgia--drug therapy<br/>Neuropeptides--administration & dosage<br/>Neurotensin--analogs & derivatives<br/>Spinal Cord Injuries--drug therapy<br/>Treatment Outcome